NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Metagenomi investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to Metagenomi's registration statement for the initial public offering held between ...

NEW YORK, Sept. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX). Shareholders who purchased shares of MGX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/metagenomi-loss-submission-form/?id=105586&from=4 CLASS PERIOD: This lawsuit is on beh ...

NEW YORK, Sept. 28, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company's initial public offering conducted between February 9 and 13, 2024 (the "IPO") A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 25, 2024. So what: If you purchased Metagenomi stoc ...

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Metagenomi securities pursuant and/or traceable to Metagenomi's registration statement for the initial public o ...

SAN DIEGO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities who purchased stock pursuant to and/or traceable to Metagenomi Inc.'s (NASDAQ: MGX) registration statement for the initial public offering (IPO) held between February 9 and 13, 2024. Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. For more information, ...

LOS ANGELES, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ: MGX) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on or about February 9, 2024, are encouraged to contact ...

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ: MGX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Metagenomi ...

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the stock of Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) pursuant and/or traceable to Metagenomi's registration statement for the initial public offering held between February 9 and 13, 2024. For more information, submit a form at Metagenomi, Inc. Shareholder Class Action Lawsuit, email I ...

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased the securities of Metagenomi Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) between February 9, 2024 and May 1, 2024, both dates inclusive (the "Class Period"). The Complaint alleges that Metagenomi introduced itself to investors during its initi ...

文章核心观点 - 公司Metagenomi在2024年2月9日至13日进行首次公开募股(IPO),以每股15美元的价格发行了625万股 [1][2][3] - Metagenomi声称与Moderna公司有长期业务合作关系,双方于2021年10月29日签订了战略合作和许可协议 [2] - 但在IPO后不到3个月的时间里,即2024年5月1日,Metagenomi宣布与Moderna"双方同意终止合作"关系 [3] - 分析师认为,这一合作关系是Metagenomi核心业务的重要组成部分,在公司发展的早期阶段失去这一合作伙伴,引发了更多疑问 [3] - 受此消息影响,Metagenomi股价从2024年5月1日的7.04美元下跌至5月2日的6.17美元 [3] 公司信息 - Metagenomi是一家"基因医药公司",声称与Moderna有长期业务合作关系 [2] - 公司于2024年2月13日完成首次公开募股(IPO),发行625万股,每股价格15美元 [1][2][3] 行业信息 - Metagenomi与Moderna的合作关系是公司核心业务的重要组成部分 [3] - 失去这一合作伙伴在公司发展的早期阶段引发了更多疑问 [3]